Nectar Lifesciences has informed that it enclosed a copy of the Certificate received from Kfin Technologies, Registrar and Share Transfer Agent (RTA) of the Company for the quarter ended on June 30, 2024.
The above information is a part of company’s filings submitted to BSE.